Outpatient percutaneous liver biopsy: Still a good option

Abstract Objective To assess security of “blind” percutaneous liver biopsy as an ambulatory procedure. Material and Methods Defining inclusion criteria, surveillance protocol, data from ultrasonography done 6 h after procedure and complications. Results We analysed 192 percutaneous liver biopsies done between 2000-2007. There were no major complications and only a small number of minor complications. There were no deaths related to the procedure. Conclusion It is possible to perform percutaneous liver biopsy as an ambulatory procedure not expecting to find threatening complications.